Alegría-Landa Victoria, Rodríguez-Pinilla Socorro María, Santos-Briz Angel, Rodríguez-Peralto José Luis, Alegre Victor, Cerroni Lorenzo, Kutzner Heinz, Requena Luis
Departments of Dermatology and Pathology, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain.
Department of Dermatology, Hospital Clínico Universitario, Salamanca, Spain.
JAMA Dermatol. 2017 Jul 1;153(7):651-659. doi: 10.1001/jamadermatol.2016.6092.
Histiocytoid Sweet syndrome is a rare histopathologic variant of Sweet syndrome. The nature of the histiocytoid infiltrate has generated considerable controversy in the literature.
The main goal of this study was to conduct a comprehensive overview of the immunohistochemical phenotype of the infiltrate in histiocytoid Sweet syndrome. We also analyze whether this variant of Sweet syndrome is more frequently associated with hematologic malignancies than classic Sweet syndrome.
This is a retrospective case series study of the clinicopathologic, immunohistochemical, and molecular features of 33 patients with a clinicopathologic diagnosis of histiocytoid Sweet syndrome was conducted in the dermatology departments of 5 university hospitals and a private laboratory of dermatopathology.
The clinical, histopathological, immunohistochemical, and follow-up features of 33 patients with histiocytoid Sweet syndrome were analyzed. In some cases, cytogenetic studies of the dermal infiltrate were also performed. We compare our findings with those of the literature.
The dermal infiltrate from the 33 study patients (20 female; median age, 49 years; age range, 5-93 years; and 13 male; median age, 42 years; age range, 4-76 years) was mainly composed of myeloperoxidase-positive immature myelomonocytic cells with histiocytoid morphology. No cytogenetic anomalies were found in the infiltrate except in 1 case in which neoplastic cells of chronic myelogenous leukemia were intermingled with the cells of histiocytoid Sweet syndrome. Authentic histiocytes were also found in most cases, with a mature immunoprofile, but they appeared to be a minor component of the infiltrate. Histiocytoid Sweet syndrome was not more frequently related with hematologic malignancies than classic neutrophilic Sweet syndrome.
The dermal infiltrate of cutaneous lesions of histiocytoid Sweet syndrome is composed mostly of immature cells of myeloid lineage. This infiltrate should not be interpreted as leukemia cutis.
组织细胞样Sweet综合征是Sweet综合征一种罕见的组织病理学变体。组织细胞样浸润的性质在文献中引发了相当大的争议。
本研究的主要目的是全面概述组织细胞样Sweet综合征浸润的免疫组化表型。我们还分析了这种Sweet综合征变体是否比经典Sweet综合征更常与血液系统恶性肿瘤相关。
这是一项回顾性病例系列研究,对5家大学医院皮肤科和一家皮肤病理学私人实验室中33例经临床病理诊断为组织细胞样Sweet综合征患者的临床病理、免疫组化和分子特征进行了研究。
分析了33例组织细胞样Sweet综合征患者的临床、组织病理学、免疫组化和随访特征。在某些病例中,还对皮肤浸润进行了细胞遗传学研究。我们将我们的研究结果与文献中的结果进行了比较。
33例研究患者(20例女性;中位年龄49岁;年龄范围5 - 93岁;13例男性;中位年龄42岁;年龄范围4 - 76岁)的皮肤浸润主要由具有组织细胞样形态的髓过氧化物酶阳性未成熟髓单核细胞组成。除1例慢性粒细胞白血病肿瘤细胞与组织细胞样Sweet综合征细胞混合的病例外,浸润中未发现细胞遗传学异常。在大多数病例中也发现了具有成熟免疫表型的真性组织细胞,但它们似乎是浸润的次要成分。组织细胞样Sweet综合征与血液系统恶性肿瘤的相关性并不比经典嗜中性Sweet综合征更常见。
组织细胞样Sweet综合征皮肤病变的皮肤浸润主要由髓系未成熟细胞组成。这种浸润不应被解释为皮肤白血病。